BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Al-Kuraishy HM, Batiha GE, Faidah H, Al-Gareeb AI, Saad HM, Simal-Gandara J. Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals. Inflammopharmacology 2022. [PMID: 36044102 DOI: 10.1007/s10787-022-01027-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Al-Kuraishy HM, Batiha GE, Al-Gareeb AI, Al-Harcan NAH, Welson NN. Receptor-dependent effects of sphingosine-1-phosphate (S1P) in COVID-19: the black side of the moon. Mol Cell Biochem 2023;:1-9. [PMID: 36652045 DOI: 10.1007/s11010-023-04658-7] [Reference Citation Analysis]
2 Zheng Z, Peng F, Zhou Y. Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19? Chinese Medical Journal - Pulmonary and Critical Care Medicine 2023. [DOI: 10.1016/j.pccm.2022.12.002] [Reference Citation Analysis]
3 Batiha GE, Al-kuraishy HM, Al-gareeb AI, Alruwaili M, Alruwaili R, Albogami SM, Alorabi M, Saad HM, Simal-gandara J. Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal. Inflammopharmacol 2022. [DOI: 10.1007/s10787-022-01087-8] [Reference Citation Analysis]
4 Al-kuraishy HM, Al-gareeb AI, Alsayegh AA, Hakami ZH, Khamjan NA, Saad HM, Batiha GE, De Waard M. A Potential Link Between Visceral Obesity and Risk of Alzheimer’s Disease. Neurochem Res 2022. [DOI: 10.1007/s11064-022-03817-4] [Reference Citation Analysis]
5 Al-Kuraishy HM, Al-Gareeb AI, Albezrah NKA, Bahaa HA, El-Bouseary MM, Alexiou A, Al-Ziyadi SH, Batiha GE. Pregnancy and COVID-19: high or low risk of vertical transmission. Clin Exp Med 2022. [PMID: 36251144 DOI: 10.1007/s10238-022-00907-z] [Reference Citation Analysis]
6 Alsubaie N, Al-kuraishy HM, Al-gareeb AI, Alharbi B, De Waard M, Sabatier J, Saad HM, Batiha GE. Statins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review. Brain Sciences 2022;12:1290. [DOI: 10.3390/brainsci12101290] [Reference Citation Analysis]
7 Alomair BM, Al-kuraishy HM, Al-gareeb AI, Al-hamash SM, De Waard M, Sabatier J, Saad HM, El-saber Batiha G. Montelukast and Acute Coronary Syndrome: The Endowed Drug. Pharmaceuticals 2022;15:1147. [DOI: 10.3390/ph15091147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]